Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 755 All time
- Disclosed funding
- $25.4B 617 disclosed amounts
- Median round
- $15.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| CV Cagent VascularCompany profile Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease | $41M | Series DSeries C+ | Healthtech | United States | Investors | |
| NH NEX Health IntelligenceCompany profile Provides AI platform to detect, predict and prevent hospital-acquired infections for NHS and global hospitals Provides AI platform to detect, predict and prevent hospital-acquired infections for NHS and global hospitals | €1M | Pre-SeedPre-seed | Healthtech | United Kingdom | Investors | |
| VI Vortex ImagingCompany profile Develops a compact computational ultrasound system for standardized 3D volumetric imaging at the point of care Develops a compact computational ultrasound system for standardized 3D volumetric imaging at the point of care | $12M | Undisclosed | Healthtech | United States | Investors | |
| AB Accro BioscienceCompany profile Clinical-stage medicines targeting inflammation and regulated cell-death pathways in immune-mediated disease. Clinical-stage medicines targeting inflammation and regulated cell-death pathways in immune-mediated disease. | $50M | Series CSeries C+ | Healthtech, Biotech | United States | Investors | |
| KH Kin HealthCompany profile Records medical appointments and translates them into plain-language summaries for patients to act on Records medical appointments and translates them into plain-language summaries for patients to act on | $9M | Seed | Healthtech | United States | Investors | |
| FT Full-Life TechnologiesCompany profile Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing | $150M | Series D+DebtUndisclosed | Healthtech, Biotech | China | Investors | |
| VT Violet TherapeuticsCompany profile Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform | $4.8M | Seed+Seed | Healthtech, Biotech | United States | Investors | |
| A AlcolaseCompany profile Alcolase is developing a liposomal enzyme system intended to break down alcohol in the stomach before absorption. Alcolase is developing a liposomal enzyme system intended to break down alcohol in the stomach before absorption. | €1.5M | Undisclosed | Healthtech, Biotech | Denmark | Investors | |
| WB Wonderlab BioCompany profile Makes off-the-shelf iPSC-derived cell therapies using HLA-matched super donors for broad patient access Makes off-the-shelf iPSC-derived cell therapies using HLA-matched super donors for broad patient access | Undisclosed | StrategicUndisclosed | Healthtech, Biotech | United States | Investors | |
| CM CREATE MedicinesCompany profile Develops in vivo immune programming platform for scalable, repeat-dose immunotherapies Develops in vivo immune programming platform for scalable, repeat-dose immunotherapies | $122M | Series B | Healthtech, Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.